CRISPR Therapeutics AG named Rodger Novak as board chairman.
Novak is the founder and former CEO of CRISPR Therapeutics. He will succeed Tony Coles, who will remain with the company as a senior adviser.
CRISPR Therapeutics appoints board chairman
A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research
2021 Year in Review: Highlighting Key Investment Banking Trends
Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings
Global M&A By the Numbers: Q3 2021
CRISPR Therapeutics AG named Rodger Novak as board chairman.
Novak is the founder and former CEO of CRISPR Therapeutics. He will succeed Tony Coles, who will remain with the company as a senior adviser.